Review
doi: 10.1056/NEJMcp1001011.Clinical practice. Calcium kidney stones
Affiliations
- PMID:20818905
- PMCID: PMC3192488
- DOI: 10.1056/NEJMcp1001011
Item in Clipboard
Review
Clinical practice. Calcium kidney stones
Elaine M Worcester et al. N Engl J Med..
Display options
Format
Display options
Format
No abstract available
Comment in
- Calcium kidney stones.Latta K.Latta K.N Engl J Med. 2010 Dec 16;363(25):2470; author reply 2471. doi: 10.1056/NEJMc1011349.N Engl J Med. 2010.PMID:21158673No abstract available.
- Calcium kidney stones.Leaf DE.Leaf DE.N Engl J Med. 2010 Dec 16;363(25):2470; author reply 2471. doi: 10.1056/NEJMc1011349.N Engl J Med. 2010.PMID:21158674No abstract available.
Similar articles
- Use of the discriminant index in dynamic treatment to reduce recurrence of calcium oxalate kidney stones.Perlberg S, Azoury R, Garti N, Sarig S.Perlberg S, et al.Br J Urol. 1985 Oct;57(5):500-4. doi: 10.1111/j.1464-410x.1985.tb05855.x.Br J Urol. 1985.PMID:2998532
- Medical management of nephrolithiasis.Pak CY.Pak CY.J Urol. 1982 Dec;128(6):1157-64. doi: 10.1016/s0022-5347(17)53403-5.J Urol. 1982.PMID:6759686Clinical Trial.No abstract available.
- Consensus development summaries. Prevention and treatment of kidney stones. National Institutes of Health.[No authors listed][No authors listed]Conn Med. 1988 Jul;52(7):415-20.Conn Med. 1988.PMID:3215027No abstract available.
- Prevention and treatment of kidney stones.[No authors listed][No authors listed]J Urol. 1989 Mar;141(3 Pt 2):804-8. doi: 10.1016/s0022-5347(17)41015-9.J Urol. 1989.PMID:2645439Review.No abstract available.
- Consensus conference. Prevention and treatment of kidney stones.[No authors listed][No authors listed]JAMA. 1988 Aug 19;260(7):977-81.JAMA. 1988.PMID:3294456Review.No abstract available.
Cited by
- Risk Factors of Asymptomatic Kidney Stone Passage in Adults with Recurrent Kidney Stones.Stritt K, Fuster DG, Dhayat NA, Bonny O, Faller N, Christe A, Taha A, Ochs V, Ortlieb N, Roth B; on behalf of the NOSTONE Study.Stritt K, et al.Clin J Am Soc Nephrol. 2024 Sep 1;19(9):1130-1137. doi: 10.2215/CJN.0000000000000496. Epub 2024 Jul 19.Clin J Am Soc Nephrol. 2024.PMID:39028573
- Net intestinal transport of oxalate reflects passive absorption and SLC26A6-mediated secretion.Knauf F, Ko N, Jiang Z, Robertson WG, Van Itallie CM, Anderson JM, Aronson PS.Knauf F, et al.J Am Soc Nephrol. 2011 Dec;22(12):2247-55. doi: 10.1681/ASN.2011040433. Epub 2011 Oct 21.J Am Soc Nephrol. 2011.PMID:22021714Free PMC article.
- Antioxidant Pre-Treatment Reduces the Toxic Effects of Oxalate on Renal Epithelial Cells in a Cell Culture Model of Urolithiasis.Kizivat T, Smolić M, Marić I, Tolušić Levak M, Smolić R, Bilić Čurčić I, Kuna L, Mihaljević I, Včev A, Tucak-Zorić S.Kizivat T, et al.Int J Environ Res Public Health. 2017 Jan 23;14(1):109. doi: 10.3390/ijerph14010109.Int J Environ Res Public Health. 2017.PMID:28125004Free PMC article.
- Development of a Kidney Calcification Inhibitor Employing Image-Based Profiling: A Proof-of-Concept Study.Kletzmayr A, Bigler M, Montanari E, Kuro-O M, Hayashi H, Ivarsson ME, Leroux JC.Kletzmayr A, et al.ACS Pharmacol Transl Sci. 2020 Nov 23;3(6):1339-1351. doi: 10.1021/acsptsci.0c00153. eCollection 2020 Dec 11.ACS Pharmacol Transl Sci. 2020.PMID:33344907Free PMC article.
- Tumor lysis syndrome: A clinical review.Mirrakhimov AE, Voore P, Khan M, Ali AM.Mirrakhimov AE, et al.World J Crit Care Med. 2015 May 4;4(2):130-8. doi: 10.5492/wjccm.v4.i2.130. eCollection 2015 May 4.World J Crit Care Med. 2015.PMID:25938028Free PMC article.Review.
References
- Stamatelou KK, Francis ME, Jones CA, Nyberg LM, Jr, Curhan GC. Time trends in reported pevalence of kidney stones in the United States:1976–1994. Kid Int. 2003;63:1817–1823. - PubMed
- Borghi L, Meschi T, Guerra A, Novarini A. Randomized prospective study of a nonthiazide diuretic, indapamide, in preventing calcium stone recurrences. J Cardiovascular Pharmacology. 1993;22(Suppl 6):S78–S86. - PubMed
- Ettinger B, Pak CY, Citron JT, Thomas C, Adams-Huet B, Vangessel A. Potassium-magnesium citrate is an effective prophylaxis against recurrent calcium oxalate nephrolithiasis. Journal of Urology. 1997;158(6):2069–2073. 158(6) - PubMed
- Ettinger B, Citron JT, Livermore B, Dolman LI. Chlorthalidone reduces calcium oxalate calculous recurrence but magnesium hydroxide does not. Journal of Urology. 1988;139:679–684. - PubMed
- Ettinger B, Tang A, Citron JT, Livermore B, Williams T. Randomized trial of allopurinol in the prevention of calcium oxalate calculi. N Engl J Med. 1986;315:1386–1389. - PubMed
Publication types
MeSH terms
Substances
Related information
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources